TVTX β€” TRAVERE THERAPEUTICS INC

Ownership history in Point72 (DIFC) Ltd  Β·  2 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in TRAVERE THERAPEUTICS INC (TVTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.01% (2025 Q2)
πŸ“Š Avg. % of fund
0.01%
πŸ“… First filed
2024 Q2
πŸ“… Last filed
2025 Q2
⏱ Quarters held
2
% of Fund (quarterly)    TVTX price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 2 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 19,767 -1,548 -7.3% 0.01% $293K $14.80
2024 Q2 INITIATED 21,315 β€” β€” 0.01% $175K β€”

🏒 Other funds also holding TVTX

As of 2025 Q4 β€” sorted by position size

Rock Springs Capital Management LP 3Y 7Y 4.33% Knott David M Jr 3Y 3.29% PERCEPTIVE ADVISORS LLC 3Y 7Y 2.91% Eversept Partners, LP 3Y 7Y 2.26% EMERALD ADVISERS, LLC 3Y 7Y 1.88% ARMISTICE CAPITAL, LLC 3Y 7Y 1.71% Exome Asset Management LLC 1.63% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 1.32% Kynam Capital Management, LP 3Y 1.26% Lisanti Capital Growth, LLC 3Y 7Y 1.25%
← Back to Point72 (DIFC) Ltd Holdings